Actively Recruiting
LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Led by Wuxi Hisky Medical Technology Co Ltd · Updated on 2025-01-31
365
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
Sponsors
W
Wuxi Hisky Medical Technology Co Ltd
Lead Sponsor
B
Beijing Tsinghua Changgeng Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.
CONDITIONS
Official Title
LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with non-alcoholic fatty liver disease (NAFLD) according to official guidelines
- Age over 18 years
- No other liver diseases such as viral hepatitis, drug-induced liver injury, or autoimmune liver disease
- Underwent iLivTouch examination within 14 days before or after liver biopsy
- No history of excessive alcohol consumption (less than 140g/week for males and less than 70g/week for females)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Tsinghua Changgung Hospital (BTCH) affiliated to Tsinghua University
Beijing, Beijing Municipality, China, 102218
Actively Recruiting
Research Team
L
Lai Wei
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here